Viewing Study NCT00144703


Ignite Creation Date: 2025-12-24 @ 7:21 PM
Ignite Modification Date: 2026-01-05 @ 6:29 PM
Study NCT ID: NCT00144703
Status: COMPLETED
Last Update Posted: 2012-01-26
First Post: 2005-09-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module